| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TEREX CORP | Director | Common Stock, $ .01 par value | 64,456 | $3,440,661 | $53.38 | 02 Feb 2026 | Direct |
| REV Group, Inc. | Director | Common Stock | 0 | $0 | $60.81 | 02 Feb 2026 | Direct |
| Acasti Pharma Inc. | Director | Stock Options (Right to Buy) | 45,000 | 28 Sep 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TEX | TEREX CORP | 02 Feb 2026 | 2 | $0 | 4 | Director | 04 Feb 2026, 12:51 |
| TEX | TEREX CORP | 02 Feb 2026 | 0 | $0 | 3 | Director | 04 Feb 2026, 12:48 |
| REVG | REV Group, Inc. | 02 Feb 2026 | 2 | $0 | 4 | Director | 02 Feb 2026, 19:04 |
| REVG | REV Group, Inc. | 03 Dec 2025 | 1 | $0 | 4 | Director | 05 Dec 2025, 20:40 |
| REVG | REV Group, Inc. | 05 Dec 2024 | 1 | $0 | 4 | Director | 09 Dec 2024, 20:11 |
| REVG | REV Group, Inc. | 08 Dec 2023 | 1 | $0 | 4 | Director | 12 Dec 2023, 19:13 |
| REVG | REV Group, Inc. | 08 Dec 2022 | 1 | $0 | 4 | Director | 12 Dec 2022, 15:05 |
| GRCE | Acasti Pharma Inc. | 28 Sep 2022 | 1 | $0 | 4 | Director | 30 Sep 2022, 16:19 |
| REVG | REV Group, Inc. | 09 Dec 2021 | 1 | $0 | 4 | Director | 13 Dec 2021, 16:10 |
| GRCE | Acasti Pharma Inc. | 12 Nov 2021 | 1 | $0 | 4 | Director | 16 Nov 2021, 15:16 |